MRD Testing: From Residual Disease to Real Decisions with Chris Hourigan and Gary Pestano
Chris Hourigan and Gary Pestano explore the evolution of Molecular Residual Disease (MRD) testing in oncology, highlighting its progression from basic detection to a quantitative, actionable tool for clinical decisions. They discuss the challenges in assay development and the…